- Home
- TYRA vs SIFY Comparison
TYRA vs SIFY Comparison
Compare TYRA & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- SIFY
- Stock Information
- Founded
- TYRA 2018
- SIFY 1995
- Country
- TYRA United States
- SIFY India
- Employees
- TYRA N/A
- SIFY N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- SIFY Computer Software: Programming Data Processing
- Sector
- TYRA Health Care
- SIFY Technology
- Exchange
- TYRA Nasdaq
- SIFY Nasdaq
- Market Cap
- TYRA 844.2M
- SIFY 844.3M
- IPO Year
- TYRA 2021
- SIFY 1999
- Fundamental
- Price
- TYRA $14.27
- SIFY $10.83
- Analyst Decision
- TYRA Strong Buy
- SIFY
- Analyst Count
- TYRA 5
- SIFY 0
- Target Price
- TYRA $31.20
- SIFY N/A
- AVG Volume (30 Days)
- TYRA 261.6K
- SIFY 293.8K
- Earning Date
- TYRA 11-05-2025
- SIFY 10-25-2025
- Dividend Yield
- TYRA N/A
- SIFY N/A
- EPS Growth
- TYRA N/A
- SIFY N/A
- EPS
- TYRA N/A
- SIFY N/A
- Revenue
- TYRA N/A
- SIFY $466,564,151.00
- Revenue This Year
- TYRA N/A
- SIFY N/A
- Revenue Next Year
- TYRA N/A
- SIFY $12.69
- P/E Ratio
- TYRA N/A
- SIFY N/A
- Revenue Growth
- TYRA N/A
- SIFY 9.09
- 52 Week Low
- TYRA $6.42
- SIFY $2.61
- 52 Week High
- TYRA $17.78
- SIFY $17.85
- Technical
- Relative Strength Index (RSI)
- TYRA 49.37
- SIFY 41.67
- Support Level
- TYRA $13.35
- SIFY $10.78
- Resistance Level
- TYRA $15.38
- SIFY $11.70
- Average True Range (ATR)
- TYRA 0.92
- SIFY 1.02
- MACD
- TYRA -0.14
- SIFY -0.27
- Stochastic Oscillator
- TYRA 35.37
- SIFY 13.48
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.